Chronic inflammation increases the risk of developing one of several types of cancer. Inflammatory responses are currently thought to be controlled by mechanisms that rely on transcriptional networks that are distinct from those involved in cell differentiation 1-3 . The orphan nuclear receptor NR5A2 participates in a wide variety of processes, including cholesterol and glucose metabolism in the liver, resolution of endoplasmic reticulum stress, intestinal glucocorticoid production, pancreatic development and acinar differentiation 4-8 . In genome-wide association studies 9,10 , single nucleotide polymorphisms in the vicinity of NR5A2 have previously been associated with the risk of pancreatic adenocarcinoma. In mice, Nr5a2 heterozygosity sensitizes the pancreas to damage, impairs regeneration and cooperates with mutant Kras in tumour progression 11 . Here, using a global transcriptomic analysis, we describe an epithelialcell-autonomous basal pre-inflammatory state in the pancreas of Nr5a2 +/− mice that is reminiscent of the early stages of pancreatitisinduced inflammation and is conserved in histologically normal human pancreases with reduced expression of NR5A2 mRNA. In Nr5a2 +/− mice, NR5A2 undergoes a marked transcriptional switch, relocating from differentiation-specific to inflammatory genes and thereby promoting gene transcription that is dependent on the AP-1 transcription factor. Pancreatic deletion of Jun rescues the pre-inflammatory phenotype, as well as binding of NR5A2 to inflammatory gene promoters and the defective regenerative response to damage. These findings support the notion that, in the pancreas, the transcriptional networks involved in differentiationspecific functions also suppress inflammatory programmes. Under conditions of genetic or environmental constraint, these networks can be subverted to foster inflammation.
, is also associated with reduced NR5A2 protein levels (P = 0.028, β = − 0.57) (Extended Data Fig. 1 ). This suggests that NR5A2 expression may underlie susceptibility to PDAC.
We used Nr5a2 +/− mice to identify the mechanisms that favour impaired regeneration in the pancreas and PDAC. The pancreas of an adult Nr5a2 +/− mouse is histologically normal, as are its expression of pancreatic transcription factors and digestive enzymes (Extended Data Fig. 2a, b) . RNA sequencing (RNA-seq) showed that 926 and 100 genes were significantly upregulated or downregulated, respectively, in pancreases from 8-10-week-old Nr5a2 +/− mice, when compared to wild-type mice. Gene set enrichment analysis (GSEA) revealed that 21 out of 23 gene sets that were over-represented in Nr5a2 +/− mice, and 68% of upregulated genes, belong to inflammatory pathways (Fig. 1a, b  and Supplementary Tables 2, 3 ). Among these genes are those coding for chemokines (Ccl5 and Ccl7), complement components (C1qb and C3) and metalloproteases. Results were confirmed by quantitative PCR (qPCR) with reverse transcription (qRT-PCR) (Fig. 1c) . Corresponding changes in H3K27ac or H3K27me3 at the promoters of differentially regulated genes were also observed (data not shown). mRNA and protein analyses using fresh tissue, isolated acini and immunohistochemistry confirmed upregulation of inflammatory mediators in acinar cells ( +/− pancreases did not reveal significant differences between the two, and a role for a ductal cell contribution to inflammatory gene expression was excluded ( Fig. 1f and Extended Data Figs 2d-f, 3). Pancreas-selective inactivation of one Nr5a2 allele, and biallelic Nr5a2 inactivation in myeloid cells, showed that the defect is specific to pancreatic epithelial cells (Extended Data Fig. 4 ), which indicates that Nr5a2 haploinsufficiency generates an epithelial-cell-autonomous basal pre-inflammatory state.
To assess whether similar transcriptomic changes occur in humans, we compared histologically normal pancreases (n = 95) 12 with high versus low NR5A2 expression (top versus bottom quartile) (n = 24 per group). Seventy-eight per cent of genes for which expression was upregulated in Nr5a2 +/− pancreases (n = 718) were also differentially expressed in human samples (P < 0.05). Of these differentially upregulated genes, 92% were significantly upregulated. By contrast, 44% of downregulated genes (n = 64) were differentially represented (P < 0.05) and only 50% of them were downregulated (Fig. 1g) . Overall, genes that were upregulated in Nr5a2 +/− mice were also upregulated Letter reSeArCH 5 ). By contrast, downregulated genes did not follow a concordant pattern in mouse and human pancreases (P = 0.58). The conservation of findings across species provides a framework for understanding the relationship between the NR5A2 genotype, NR5A2 mRNA expression and PDAC in mice.
Analysis of public ChIP-seq (chromatin immunoprecipitation followed by sequencing) datasets 6 pertaining to pancreatic NR5A2 showed that the promoters of 89% of the genes that had upregulated expression in Nr5a2 +/− mice contain putative NR5A2 binding sites, but only 7% actually exhibit NR5A2 binding within 2.5 Kb of the transcriptional start site. This suggests the participation of an indirect mechanism (Fig. 2a) . Promoter scanning analysis of upregulated genes showed significant enrichment of AP-1 and NF-κ B binding motifs, among others. A similar enrichment was found when computing the list of upregulated genes with GSEA using the MSigDB C3 transcription factor target gene-set collection (http://software.broadinstitute. org/gsea/msigdb/collections.jsp). Jun (also known as c-Jun), Junb, Jund and Fos (also known as c-Fos) mRNA and their corresponding proteins were significantly upregulated in Nr5a2 +/− pancreases (Fig. 2b, c) . We confirmed that these changes occurred in epithelial cells using freshly isolated acini and immunohistochemistry (Extended Data Fig. 3g ). Phospho-JUN (p-JUN) and phospho-JNK (p-JNK) were also upregulated in Nr5a2 +/− pancreases and isolated acini ( Fig. 2d and Extended Data Fig. 3h ). ChIP followed by qPCR (ChIP-qPCR) showed significantly increased binding of NR5A2 to the promoters of Fos and Fosl1 (also known as Fra1)-but not to those of Jun, Junb and Jund-in Nr5a2 +/− pancreases compared to wild-type mouse pancreases (Fig. 2e ).
NR5A2 expression in human embryonic kidney (HEK293) cells led to a dose-dependent decrease of JUN mRNA (Fig. 2f ), indicating that changes in NR5A2 levels can modulate JUN expression. ChIP-qPCR showed increased binding of JUN, JUNB, JUND and FOS to the promoter of upregulated inflammatory genes in Nr5a2 +/− pancreases (Fig. 2g ). The basal pre-inflammatory transcriptome of Nr5a2 +/− mice suggests a subclinical pancreatitis-like state. We compared the transcriptomes of wild-type and Nr5a2 +/− pancreases 8, 24 and 48 h after induction of mild acute pancreatitis (with 7 doses of caerulein), using RNA-seq. Principal component analysis highlighted the divergence of the basal transcriptomes of wild-type and Nr5a2 +/− pancreases; these differences were completely but transiently eroded 8 h after pancreatitis induction. The basal transcriptome of Nr5a2 +/− pancreases was similar to that of wild-type mouse pancreases at 8 h (Fig. 1a) . The differences between the set of genes upregulated in Nr5a2 +/− pancreases under basal conditions and those upregulated in wild-type pancreases were notably reduced 8-24 h after pancreatitis induction; a similar pattern of reduced differences between Nr5a2 +/− and wild-type pancreases was observed for the downregulated genes. The expression of a random set of genes was unaffected (Extended Data Fig. 5a ). Consistently, although there was a strong upregulation of AP-1 at 8 h after induction of pancreatitis in mice of both genotypes, persistent AP-1 upregulation at 24-48 h was observed only in Nr5a2 +/− mice (Extended Data Fig. 5b ). These results indicate that Nr5a2 haploinsufficiency mimics acute pancreatitis at the transcriptome level.
The repeated caerulein dosing required to induce pancreatitis hampers the interpretation of dynamic acute signalling and transcriptional responses. Therefore, we also analysed the effects of a single dose of caerulein that did not induce pancreatitis (Extended Data Fig. 6a ). JUN, +/− pancreases (n = 4 per group). g, Scatter plot showing the relationship between expression of upregulated, downregulated or a random set of genes in Nr5a2 +/− versus control Nr5a2 +/+ mice (y axis) and in histologically normal human pancreatic samples (x axis, low versus top high quartiles of NR5A2 mRNA expression). In c, d and f, one-sided Mann-Whitney U test; * P < 0.05, * * P < 0.01. FOS, JUND, FOSL1 and FOSL2 (also known as FRA2) were upregulated to a similar extent in both wild-type and Nr5a2 +/− pancreases 30-60 min after caerulein administration, preceding STAT3 phosphorylation (Extended Data Fig. 6b ). We then analysed the expression of a subset of the genes differentially overexpressed in Nr5a2 +/− pancreases under basal conditions. By 30-60 min, one dose of caerulein was sufficient to promote an inflammatory profile in wild-type mice; this profile closely resembled that of Nr5a2 +/− pancreases. A complete resolution of this expression profile occurred in wild-type mice by 12 h (Fig. 3a, b) . To determine whether these are epithelial-cell-autonomous effects, primary acini from wild-type and Nr5a2 +/− mice were treated with vehicle or caerulein for 24 h. qRT-PCR analysis confirmed that under control conditions Nr5a2 +/− acini express higher levels of inflammatory genes than wild-type acini, and that these differences were abolished upon caerulein treatment (Extended Data Fig. 6c ).
These findings further support the notion that Nr5a2 +/− acini display a transcriptional pre-inflammatory phenotype similar to that of caerulein-treated wild-type acini.
A large fraction of inflammatory gene promoters contain putative NR5A2 binding sites that are not occupied in normal pancreas (Fig. 2a , data not shown). Accordingly, we performed ChIP-qPCR on the promoter of bona fide NR5A2 target differentiation-related genes (that is, those encoding digestive enzymes) and of inflammatory genes upregulated in Nr5a2 +/− mice. In untreated wild-type mice NR5A2 was observed to bind at the promoter of differentiation genes, but not at the promoter of inflammatory genes (Fig. 3c) . However, in untreated Nr5a2 +/− mice, the binding of NR5A2 to differentiation gene promoters was reduced and binding to inflammatory gene promoters was increased. We designate this relocation of NR5A2 between gene sets as the 'NR5A2 transcriptional switch' . A similar transcriptional switch occurred in wildtype mice 30 min after 1 dose of caerulein and the genomic distribution of NR5A2 was restored 12 h later (Fig. 3d) , supporting its physiological relevance. NR5A2 can interact with JUN in vitro 13 , and we found that both proteins co-immunoprecipitated in the pancreases of untreated Nr5a2 +/− mice and in wild-type mice 1 h after caerulein administration, but not in untreated wild-type mice (Fig. 3e) .Using sequential ChIPqPCR, NR5A2 and JUN were detected on the same immunoprecipitated chromatin regions at the promoters of C1qb, Ccl7 and Ccl8 in untreated Nr5a2 +/− mice and in wild-type mice 1 h after caerulein administration, supporting the proposition that JUN and AP-1 cooperate in producing the NR5A2 transcriptional switch ( Fig. 3f and Extended Data Fig. 7) .
NR0B2 is an NR5A2 co-repressor and target gene 14 that is highly expressed in acinar cells, shows reduced expression in Nr5a2 +/− pancreases and is dynamically regulated on caerulein administration (Extended Data Fig. 8a-e) . In humans, NR0B2 mRNA expression was significantly higher in NR5A2 high pancreases (P = 1.4 × 10 −7 ) and NR5A2 and NR0B2 levels were positively correlated with one another (R 2 = 0.312) (Extended Data Fig. 8f ), which suggests that NR0B2 contributes to the haploinsufficient phenotype. Under basal conditions in wild-type mice, NR0B2 was absent from the promoter of differentiation and inflammatory genes but it was enriched in the promoter of Jun, Junb and Jund (Extended Data Fig. 8g ). Nr5a2 +/− pancreases displayed reduced NR0B2 levels, lower occupancy of AP-1 promoters by NR0B2, reduced binding of NR5A2 at the Nr0b2 promoter and reduced complexing of NR5A2 with NR0B2 (Extended Data  Fig. 8c, g-i) , which suggests that NR0B2 ordinarily represses AP-1 expression. We validated the 266-6 mouse acinar cell line as a model to assess the effects of caerulein on AP-1 and inflammatory genes (Extended Data Fig. 9a-c) . On expression of NR0B2, Jun mRNA-but no inflammatory transcript-was reduced and NR0B2 knockdown modestly increased NR5A2 occupancy of inflammatory gene promoters (Extended Data Figs 9d, e) . The effects of NR5A2 knockdown on JUN and inflammatory gene expression were abrogated by NR0B2 overexpression (Extended Data Fig. 9f ), supporting the notion that NR5A2 modulates AP-1 expression in part through NR0B2 downregulation.
AP-1 upregulation, increased binding to inflammatory gene promoters in Nr5a2 +/− mice and the interaction of JUN and NR5A2 all suggest a crucial involvement of JUN in the basal pre-inflammatory state. Jun deletion in Nr5a2 +/− pancreases rescued the upregulation of AP-1 and inflammatory transcripts, as well as NR5A2 binding to AP-1 and inflammatory gene promoters, without affecting NR5A2 expression ( Fig. 4a-d) . On induction of acute pancreatitis, Nr5a2 +/− mice in which the Jun gene has been deleted in the pancreas (Nr5a2
;JunΔP) showed reduced damage when compared with control Nr5a2 +/− mice (Fig. 4e, f) . The normalization of the dynamic expression of AP-1 components during pancreatitis in Nr5a2 +/− ;JunΔP pancreases suggests a critical role for JUN in the phenotype of Nr5a2 +/− mice. Immunohistochemical analysis showed that the downregulation of JUN occurred selectively in acinar cells ( Fig. 4g and Extended Data Fig. 10 ). Taken together, these results indicate that Jun is required to generate the pre-inflammatory state observed in Nr5a2 +/− pancreases. +/− pancreases (n ≥ 5 per group). At least two independent experiments were performed in all cases. In b, e, f and g, onesided Mann-Whitney U test; * P < 0.05, * * P < 0.01.
In homeostatic conditions, tissue inflammation is suppressed. However, a direct link between differentiation and inflammatory programmes has not yet been proposed. Here, we demonstrate that NR5A2 is critical in restraining inflammation in normal mouse pancreas cells. Constitutive loss of one Nr5a2 allele produces a pre-inflammatory state that explains how haploinsufficiency primes tissue for damage and delays recovery, which may contribute to accelerated tumorigenesis 11 . This preinflammatory state is mediated by JUN phosphorylation and stabilization, which are hallmarks of JUN activation 15 . In Nr5a2 +/− mice, low NR5A2 and NR0B2 expression probably determine AP-1 dysregulation, which contributes to inflammatory gene expression, as occurs on induction of pancreatitis, (Fig. 3g) . In the pancreas, AP-1 is pro-inflammatory; this is unlike the situation found in the skin, in which Jun and Junb deletion in keratinocytes induces inflammatory phenotypes 16 . Our results, therefore, support the notion that the effects of AP-1 are context-dependent and tissue-specific 17, 18 . The output of the interaction of NR5A2, NR0B2 and AP-1 with gene regulatory elements is likely to be modulated by posttranscriptional modifications and chromatin accessibility: in keratinocytes, the coordinated regulation of polycomb-group and AP-1 proteins ensures canonical expression of epidermal genes during differentiation 19 .
We find chemokines and complement components among the inflammatory genes most prominently upregulated in Nr5a2 +/− pancreases. The control of inflammation from epithelial cells at the level of chemotactic stimuli suggests that leukocyte migration to tissues generates the local upregulation of cytokines, such as IL1, IL6 and TNF, which then contribute to amplifying and prolonging the inflammatory response 20 .
The findings in Nr5a2
+/− pancreases indicate that inflammation is actively repressed in normal epithelial cells, and that the genetic pre-inflammatory phenotype mimics the molecular events associated with response to pharmacological (such as caerulein) and environmental stimuli. Indeed, both conditions are associated with a switch in the chromatin distribution of NR5A2, which shifts from the promoters of pancreatic differentiation genes to those of inflammatory genes. Our findings in mice are relevant to human pancreatitis and PDAC, as shown by shared transcriptomic changes that indicate a pre-inflammatory state in the pancreas of human subjects with low NR5A2 mRNA levels and by the association of this pre-inflammatory state with low levels of NR5A2 and NR0B2. Although additional work is needed to establish the functional consequences of carrying PDAC-risk alleles at chr1q32.1, our results suggest that the underlying biology at this locus may involve negative regulation of NR5A2 expression. ) after one dose of caerulein, shown using qRT− PCR. Data refer to basal values in wild-type pancreases (n = 4 per group; two independent experiments). c, ChIP-qPCR showing differential promoter occupancy by NR5A2 under basal conditions (n = 3 per group). d, ChIPqPCR showing NR5A2 switching from the promoter of pancreatic genes to the promoter of inflammatory genes after one caerulein dose in wild-type mice (black, pancreatic genes; orange, AP-1 genes; blue, inflammatory genes) (n = 3 per group; two independent experiments). e, Co-immunoprecipitation and western blot showing that NR5A2 and JUN are part of the same complex in Nr5a2 +/− pancreases under basal conditions and in wild-type mouse pancreases after one dose of caerulein, but not in wild-type mouse pancreases under basal conditions (at least two independent experiments). f, Sequential ChIP-qPCR of JUN-NR5A2 and NR5A2-JUN to assess promoter binding in wild-type pancreases under basal conditions, and 1 h after caerulein dosing (see Extended Data Fig. 7 ) (n = 3 pools of 3 pancreases). One-sided MannWhitney U test; * P < 0.05, * * P < 0.01. g, Proposed model of the NR5A2 transcriptional switch. Under basal conditions in wild-type mice, NR5A2 is bound to acinar gene promoters as well as to the promoter of Nr0b2. In this condition, AP-1 proteins show weak binding to inflammatory gene promoters. By contrast, in untreated Nr5a2 +/− mice, and in wild-type mice that have received caerulein, NR5A2 is weakly bound to the promoter of acinar genes but shows increased binding to the promoters of Fos, Fosl1 and inflammatory genes; AP-1 proteins also show increased binding to these promoters. In wildtype mice dosed with caerulein, there is a transient redistribution of NR5A2 to AP-1 genes, and of AP-1 proteins to inflammatory genes. NR0B2 levels are reduced in untreated Nr5a2 +/− mice and in wild-type mice that have received caerulein. This is accompanied by reduced binding to AP-1 promoters, which suggests that NR0B2 participates in the regulation of AP-1 gene expression.
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No statistical methods were used to pretermine sample size. The investigators were not blinded to allocation during experiments but were blinded to outcome assessment. Mice and experimental manipulations. The following mouse strains were used: 25 . Pancreasspecific Nr5a2-heterozygous and Jun-deficient mice were generated by crossing Nr5a2 lox/+ and Jun lox/lox mice with Ptf1a cre/+ mice, respectively. All crosses were maintained in a predominantly C57BL/6 background. Littermate control mice were used. All experiments were performed using 8-14-week-old mice. All animal procedures were approved by local and regional ethics committees (Institutional Animal
) administered intraperitoneally. Mice were killed by cervical dislocation at the indicated time points.
The number of mice used in each experiment is shown in the legend of each figure. For most experiments, at least five mice per group were used; if different numbers of mice were included in each group, the lowest number is provided. No specific randomization method was used. Acinar cell isolation. Acinar cells were isolated by collagenase digestion and maintained at 37 °C in Dulbecco's modified Eagle medium containing 2% bovine serum albumin and 10 mM 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid as previously described 26 . Acini were treated either with caerulein (100 pM) or with saline for 24 h before RNA and protein isolation. Immunofluorescence and immunohistochemical analyses. Immunofluorescence and immunohistochemical analyses were performed using 3-μ m sections of formalin-fixed paraffin-embedded tissues, unless otherwise indicated. After deparaffinization and rehydration, antigen retrieval was performed by boiling in citrate buffer pH 6 for 10 min. For immunofluorescence, the sections were incubated for 45 min at room temperature with 3% BSA, 0.1% Triton X-100-PBS and then with the primary antibody overnight at 4 °C. For double or triple immunofluorescence, the corresponding antibodies were added simultaneously and incubated overnight at 4 °C. Sections were then washed with 0.1% Triton-PBS, incubated with the appropriate fluorochrome-conjugated secondary antibody, and nuclei were counter-stained with DAPI. After washing with PBS, sections were mounted with Prolong Gold Antifade Reagent (Life Technology).
For immunofluorescence quantification of Cd45 + cells, fresh-frozen tissues were used. Sections were fixed with 4% paraformaldehyde for 10 min at room temperature with gentle rotation, washed with PBS and incubated with 3% BSA and 0.1% Triton-PBS for 45 min at room temperature, followed by overnight incubation with primary antibodies recognizing PTF1a (gift from B. Bréant, INSERM) and Cd45 (NB110-93609, Novus Biologicals). After washing with PBS, sections were incubated with the appropriate fluorochrome-conjugated secondary antibodies, and nuclei were counter-stained with DAPI. After washing with PBS, sections were mounted as described. Images were analysed with Definiens Developer XD v.2.5 software (Definiens): a script was developed in-house for single-cell segmentation. Afterwards, cells were classified into subtypes by calculating the nuclear and cytoplasmic intensity of the different markers. Owing to the low quantities of marker-positive cells, a picture gallery of all single positives was generated and false-positive images were manually discarded by one of the co-authors (D.M.) for maximum accuracy; this process was performed in a blinded fashion. There were no differences between wild-type and Nr5a2 +/− mice, and only the raw uncurated results are shown in Extended Data Fig. 2e .
For immunohistochemical analyses, after antigen retrieval endogenous peroxidase was inactivated with 3% H 2 O 2 -methanol for 30 min at room temperature. Sections were incubated with 2% BSA-PBS for 1 h at room temperature, and incubated with the primary antibody. After washing, the Envision secondary reagent (DAKO) was added for 40 min at room temperature and sections were washed three times with PBS. 3,30-Diaminobenzidine tetrahydrochloride (DAB) was used as a chromogen. Sections were lightly counterstained with haematoxylin, dehydrated and then mounted. A non-related IgG was used as a negative control.
To identify ductal cells, the Dolichos biflorus agglutinin (DBA)-streptavidin visualization system was used (Discovery DAB Map Kit, RUO, Ventana). Sections were incubated with biotinylated DBA (1:1000; Vector Laboratories B-1035), washed and incubated with streptavidin-peroxidase. Reactions were developed using DAB. Histological images were acquired with a Nikon TE2000 microscope and the percentage of cells expressing DBA was quantified.
To quantify Cd45 + leukocytes using immunohistochemistry, an automated immunostaining platform was used (Ventana Discovery XT, Roche). Antigen retrieval was first performed with boiling citrate buffer pH 6.0; endogenous peroxidase was blocked and slides were incubated with rat monoclonal anti-CD45 (5C16, 1:500; Novus Biologicals, NB110-93609). Slides were incubated with the corresponding secondary antibodies (biotinylated rabbit anti-rat Ig, Vector Labs) and visualization systems (OmniRabbit, Ventana, Roche) conjugated with horseradish peroxidase. Immunohistochemical reactions were developed using DAB and nuclei were counterstained with haematoxylin. Finally, the slides were dehydrated, cleared and mounted for microscopic evaluation. Whole digital slides were acquired with a scanner (Axio Scan Z1, Zeiss) and images captured with Zen Software (Zeiss). Image analysis and quantification were performed using with the AxioVision software package (Zeiss). After selecting regions of interest, areas were selected for quantification and exported as subset TIFF images. Images with artefactual staining or cutting artefacts were eliminated. Afterwards, the images from all slides were chosen for automatic quantification (AxioVision 4.6, Zeiss) using a script for each antibody. For Cd45 quantification, positivity was evaluated in one phase (phase 1, positive) and compared with total tissue area (phase 2). The output results were then exported as Excel files with scoring data for each TIFF file. Data obtained were then compiled and appropriately assessed. Histological scoring of mouse pancreases. Inflammation-related histological parameters (oedema, inflammatory cell infiltration and acino-ductal metaplasia) were scored blindly according to the grade of severity (0-3). Flow cytometry analysis of inflammatory cells. In brief, mouse pancreases were injected in situ with collagenase P (1 mg/mL) (Roche), transferred to cold collagenase and minced. After incubating at 37 °C for 20 min with mild shaking, collagenase was inactivated with 5% cold FBS in HBSS and the pancreas was disaggregated and filtered twice through a 70-μ M strainer. After centrifugation for 2 min at 300g and resuspension (2% chelated FBS, 2 mM EDTA, supplemented with DNase in HBSS) (Ambion), live cells were counted, incubated with blocking buffer and subsequently with primary antibody for 1 h at room temperature. Cell suspensions were analysed through a FACS ARIA Ilu sorter coupled to a LSR Fortessa analyser with 10 different markers ( Fig. 1f and Extended Data Fig. 2d ). Mice with low counts of total live cells were not considered in the analyses. For each condition, ≥ 5 mice were used. RNA-seq and data processing in mouse cells. Total pancreatic RNA was isolated using guanidine thiocyanate, followed by acid phenol-chloroform extraction. RNA integrity numbers ranged from 6.6 to 9.2, when assayed by laboratory chip technology on an Agilent 2100 Bioanalyzer. PolyA + RNA was extracted and randomly fragmented, converted to double stranded cDNA and processed through subsequent enzymatic treatments of end-repair, dA-tailing and ligation to adapters according to Illumina's 'TruSeq RNA Sample Preparation Guide' (Part # 15008136 Rev. A; for samples Big104, Big90, Big92, Big18, Big277, Big278, Big33, Big87, Big94, Big113, Big17, Big86) or Illumina's 'TruSeq RNA Sample Preparation v.2 Protocol' (Part # 15026494 Rev. C; for samples Big408, Big409, Big410, Big416, Big417, Big423, Big454, Big459, Big461, Big465, Big467 and Big470). The adaptor-ligated library was completed by limited-cycle PCR with Illumina PE primers (10 cycles, or 8 cycles for samples using the v.2 protocol). The resulting purified cDNA library was applied to an Illumina flow cell for cluster generation (TruSeq cluster generation kit v.5) and sequenced on the Genome Analyzer IIx with SBS TruSeq v.5 reagents, according to the manufacturer's protocols. Three pancreases were analysed for each genotype (wild type or Nr5a2 Image analysis and per-cycle base-calling were performed with Illumina real time analysis software (RTA1.13). Conversion to FASTQ read format with the ELAND algorithm (v.2e) was performed with CASAVA-1.8 (Illumina). These files contain only reads that passed 'chastity' filtering (tagged with an 'N' , for * NOT filtered* in the sequence identifier line). Quality check was done using fastqc (v.0.9.4, Babraham Bioinformatics) and raw reads were aligned to the NCBI37/mm9 version of the mouse genome. Tophat5 (v.2.0.4) was used for alignment with the following parameters: -bowtie1,-max-multihits 5,-genomeread-mismatches 1-segment-mismatches 1-segment-length 20-splice-mismatches 0. Gene expression was quantified with cufflinks (v.2.0.2) with the following parameters: -N, -u. Further, gene expression values were normalized for library size with cuffnorm, with the following parameters: -o -L-library-norm-method classic-fpkm. Cuffdiff was used to find differential gene expression among conditions with the following parameters: -num-threads 16, -multi-read-correct, Letter reSeArCH -frag-bias-correct. Differentially expressed genes were considered with q-value of less than 0.05 (adjusted P values found using an optimized false discovery rate approach). ChIP-seq data processing. SRR389293 and SRR389294 images were downloaded from the Gene Expression Omnibus website 6 . The quality check was performed using fastqc (v.0.9.4, Babraham Bioinformatics). ChIP-seq reads were aligned to the mouse reference genome NCBI37/mm9 (accessed July 2007) with BurrowsWheeler Aligner (bwa, v.0.5.9-r16) allowing 0-1 mismatches. Uniquely aligned reads were converted to BED format. Macs14 (v.1.4.1 20110622) was used for peak calling using the following parameters: -t SRR389393, -c SRR389294 -f BED -g mm. Other parameters were used as default. PeakAnalyzer 1.4 was used to annotate NR5A2 binding sites. Motif enrichment was identified with the MEME suite using the default parameters. Reads were directionally extended to 300 bp and, for each base pair in the genome, the number of overlapping sequence reads was determined and averaged over a 10-bp window to create a wig file to visualize the data in the University of California Santa Cruz (UCSC) genome browser. Principal component analysis. The Pearson correlation was calculated from the expression value (expressed as fragments per kilobase of transcript per million mapped reads) of each gene for each sample by using the 'cor' command in R (https://www.r-project.org/). Principal component analysis was performed using the 'prcomp' command in R, from the correlation value of each sample. GSEA. The list of genes was ranked by the 't-stat' statistical value from the cuffdiff output file. The list of pre-ranked genes was then analysed with GSEA for Gene Ontology (GO) database. Significantly enriched GO terms were identified using a false discovery rate q value of less than 0.25. The analyses were carried out as defined in http://www.broadinstitute.org/gsea/doc/GSEAUserGuideFrame. html?Interpreting_GSEA. Singular enrichment analysis. The differentially expressed gene sets were computed at the molecular signature dataset of GSEA, using the Biological Processes dataset. Human transcriptome RNA-seq analysis. Histologically normal fresh frozen pancreatic tissue samples (n = 95) from patients with pancreatic cancer (n = 79) (Mayo Clinic; Memorial Sloan Kettering Cancer Center) or from organ donors (n = 16) (Penn State College of Medicine and Gift of Life Donor Program) were used. Histological review was performed at each participating institution. Subjects of self-reported non-European ancestry and those with a history of neo-adjuvant therapy before surgery were excluded from the study. All relevant ethical regulations were followed. The project was approved by the Institutional Review Boards of Memorial Sloan Kettering Cancer Center, the Mayo Clinic and Georgetown Universities; exemption for the work with human tissue samples at NIH was approved by the NIH Office of Human Subject Research. Human samples were anonymized. Written informed consent was obtained from human subjects.
RNA was isolated with the mirVana kit (Ambion). Samples with RNA integrity numbers of greater than 7.5 (1 μ g) were subject to massive parallel pairedend sequencing on the Illumina HiSeq2000 sequencing platform (TruSeq v.3 chemistry) at the CCR Sequencing Facility of the National Cancer Institute, as previously described 27 . Read alignment (MapSplice 28 ) and gene expression quantification (in transcripts per million mapped reads, RSEM v.1.2.14 12, 29 ) was performed using settings and reference data published by The Cancer Genome Atlas University of North Carolina pipeline (https://webshare.bioinf.unc.edu/ public/mRNAseq_TCGA/, UNC_mRNAseq_summary.pdf) and the 'UCSC gene' track (hg19/GRCh37) for gene annotation. We compared human samples in the top and bottom quartile of NR5A2 mRNA levels for expression of genes identified as differentially expressed in the two mouse strains (log 2 -fold change > 1 or < -1) and a set of random genes; only those genes for which a bona fide orthologue was found in the human genome were included (upregulated, n = 718; and downregulated, n = 64). A random list of genes was used for comparison (n = 173). Logistic regression models based on upper quantile normalized transcripts per million mapped reads expression values were conducted using R and Bioconductor with adjustments for age, gender and study. Protein expression-quantitative trait locus analysis. Protein expressionquantitative trait locus analysis was conducted using human PDAC tissue samples from patients of European ancestry, by assessing NR5A2 protein levels in formalin-fixed paraffin-embedded tissue samples (n = 110) on tissue microarrays generated at the Mayo Clinic. Immunohistochemistry was performed with rabbit polyclonal anti-NR5A2 antibodies (HPA005455, Sigma-Aldrich) at 1:300 dilution. NR5A2 staining was scored based on intensity (on a scale from 0-3: 0, negative; 1, weak; 2, positive; and 3, strong) and the proportion of reactive cells (0-100%). Histoscore was calculated as staining intensity × percentage of cells. When more than one core was available from a given tumour, the mean score was used. TaqMan genotyping for the single nucleotide polymorphism marking the PDAC risk locus on chr1q32.1 in NR5A2 (rs3790844; genotyping assay: C__27483560_10, Thermo Fisher Scientific) was performed on blood DNA from the same patients. Protein expression-quantitative trait loci were assessed by linear regression for additive genetic effects on NR5A2 expression based on mean histoscore and quantiles of mean histoscore (group 1, histoscore of less than 120; group 2, histoscore of 120 to 149; group 3, histoscore of 150 to 169; group 4, histoscore of 170 to 209; and group 5 histoscore of 210 and above) with adjustments for age, gender, body mass index and tissue microarray slide. Comparison of genotypes and NR5A2 expression was performed using mean histoscore quantiles. The Institutional Review Boards of the participating institutions approved the project. Quantitative RT-PCR. Total RNA was treated with DNase I (Ambion) for 30 min at 37 °C and cDNAs were prepared according to the manufacturer's specifications, using the TaqMan reverse transcription reagents (Applied Biosystems, Roche). qRT-PCR analysis was performed using the SYBR Green PCR master mix and an ABIPRISM 7900HT instrument (Applied Biosystems). The sequence of the primers used is provided in Supplementary Table 4 . Expression levels were normalized to endogenous Hprt mRNA levels using the Δ Δ C t method. The results shown are representative of at least four biological replicates. Immunoprecipitation and western blotting. For immunoprecipitation of proteins from fresh total pancreas lysates, a piece of mouse pancreas was isolated and minced in 50 mM Tris-HCl pH 8, 150 mM NaCl, 5 mM EDTA, 0.5% NP-40 containing 3× phosphatase inhibitor cocktail (Sigma-Aldrich) and 3× EDTA-free complete protease inhibitor cocktail (Roche). Lysates were briefly sonicated until the protein solution was clear, cleared for 10 min at 11,000 r.p.m. at 4 °C and then the supernatant was recovered.
Antibody-coated protein A or protein G dynabeads (Life Technology) were used for immunoprecipitation. In brief, beads were washed three times with PBS and incubated with anti-NR5A2 or normal goat IgG overnight at 4 °C. After washing three times with PBS and twice with coupling buffer (27.3 mM sodium tetraborate, 72.7 mM boric acid), the dry beads were incubated overnight at 4 °C in freshly prepared 38 mM dimethyl pimelimidate dihydrochloride in 0.1 M sodium tetraborate. Afterwards, beads were washed three times with coupling buffer and once with 1 M Tris pH 9. Then, 1 ml of the Tris solution was added to the beads and incubated for 10 min at room temperature with rotation to block amino groups and stop crosslinking. Finally, beads were washed three times with storage buffer (6.5 mM sodium tetraborate/boric acid) and stored at 4 °C until used. Protein lysates (1-5 mg, cells; 10-15 mg, tissues) were then incubated overnight at 4 °C with antibody-coated dynabeads (Thermo Fisher Scientific). Bound immune complexes were washed twice with lysis buffer containing NP-40, and then eluted by boiling in 2× Laemmli buffer (10% glycerol, 2% sodium dodecyl sulphate and 0.125 M Tris-HCl pH 6.8) for 5 min.
For co-immunoprecipitation from transfectants, HEK293 cells transfected with the corresponding plasmids were lysed in 50 mM Tris-HCl pH 8, 150 mM NaCl, 5 mM EDTA, 0.5% NP-40 for 30 min at 4 °C. After a brief sonication, cells were cleared by centrifugation for 10 min at 11,000 r.p.m. and the supernatant was recovered. Lysates were pre-cleared with protein A-or protein G-agarose beads and 2 μ g of normal rabbit IgG (Sigma-Aldrich) and then immunoprecipitated with anti Flag-M2 affinity gel (A2220), EZview Red anti-HA (E6779) (Sigma-Aldrich) for 2 h at 4 °C. The immune complexes were then pelleted by centrifugation and washed twice in NP-40 lysis buffer for 10 min at 4 °C. After washing, 2× Laemmli buffer was added and a fraction of the material eluted by boiling was loaded onto a SDS-PAGE and processed for western blotting. For immunoprecipitation with anti-NR5A2, antibody (2 μ g) was added and incubated overnight.
For western blotting, proteins were extracted from pancreatic tissue, isolated acinar cells or cultured cells using either Laemmli buffer or lysis buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 5 mM EDTA and 0.5% NP-40) supplemented with protease inhibitor and phosphatase inhibitor cocktails. Protein concentration was measured using the BCA reagent (Biorad), or extrapolated when using Laemmli lysis buffer. Proteins were resolved by either by standard SDS-PAGE or 4-20% TGX pre-cast gels (Biorad) and transferred onto nitrocellulose membranes. The antibodies used are listed in Life Sciences Reporting Summary. Densitometry analysis of digitalised western blotting images was performed using Fiji software (NIH). ChIP. Pancreas tissue was minced, washed with cold PBS supplemented with 3× protease and phosphatase cocktail inhibitors, and then fixed with 1% formaldehyde for 20 min at room temperature. Glycine was added to a final concentration of 0.125 M for 5 min at room temperature. The fixed tissue was soaked in SDS buffer (50 mM Tris pH 8.1, 100 mM NaCl, 5 mM EDTA and 0.5% SDS) and homogenized using a douncer. The supernatant was collected after centrifugation and the chromatin was sonicated with a Covaris instrument for 40 min (20% duty cycle; 10% intensity; 200 cycle), yielding DNA fragments with a bulk size of 300-500 bp. Samples were centrifuged to pellet cell debris. The amount of chromatin isolated was quantified using nanodrop; an aliquot of this material was used as input for final quantification. Samples (0.5-1 mg of chromatin) were diluted with Triton buffer (100 mM Tris pH 8.6, 0.3% SDS, 1.7% Triton X-100
Letter reSeArCH and 5 mM EDTA) to 1 ml and pre-cleared for 2 h with a mix of protein A and G (previously blocked with 5% BSA) at 4 °C. Antibody-coated beads were added: anti-NR5A2 (1 μ g), anti-JUN (1 μ g), anti-JUNB (1 μ g), anti-FOS (5 μ g), anti-JUND (2 μ g), anti-H3K27ac (1 μ g) and anti-H3K27me3 (1 μ g). Non-related IgG was used as a control. After incubating for 3 h at 4 °C in a rotating platform, beads were successively washed with 1 ml of mixed micelle buffer (20 mM Tris pH 8.1, 150 mM NaCl, 5 mM EDTA, 5% w/v sucrose, 1% Triton X-100 and 0.2% SDS), buffer 500 (50 mM HEPES at pH 7.5, 0.1% w/v deoxycholic acid, 1% Triton X-100, 500 mM NaCl and 1 mM EDTA), LiCl detergent wash buffer (10 mM Tris at pH 8.0, 0.5% deoxycholic acid, 0.5% NP-40, 250 mM LiCl and 1 mM EDTA) and TE (pH 7.5), and then bound molecules were eluted by incubating overnight in elution buffer (containing 1% SDS and 100 mM NaHCO 3 ) at 65 °C, and treated with proteinase K solution (10 M EDTA, 40 mM Tris-HCl pH 6.5, 40 μ g ml −1 proteinase K). The eluted DNA was purified by phenol-chloroform extraction. After isolation, pelleted DNA was resuspended in 150 μ l of nuclease-free water. Gene occupancy was then analysed by real-time PCR using 1 μ l of the eluted DNA diluted in a final volume of 10 μ l. The sequence of the primers used for ChIP-qPCR is provided in Supplementary Table 5 . Sequential ChIP. Chromatin from total pancreas was isolated as described above. In brief, after the first round of immunoprecipitation all beads were washed as described for the individual ChIP. Then, 10% of the beads were transferred to a new tube and de-crosslinked. The DNA was then extracted with phenol chloroform to check the efficiency of the first ChIP. For all steps involving immunoprecipitation, low protein-binding tubes were used (Eppendorf, 022431081). For sequential ChIP, the immune complexes in the remaining 90% of beads were eluted by incubating for 30 min at 37 °C in 90 μ l of freshly prepared TE and 10 mM DTT, diluted to 2 ml with dilution buffer and incubated with anti-NR5A2 and anti-JUN antibodies overnight at 4 °C. Then, immune complexes were incubated with 40 μ l of beads for 2-4 h at 4 °C, washed, transferred to a fresh tube and eluted as described for the individual ChIP. NR5A2 and NR0B2 knock-down. NR5A2 expression was interfered using Mission shRNA lentiviral constructs purchased from Sigma-Aldrich (TRCN0000025966, t ar ge ting C CG GG CA GA AG AC TA CC TG TA CT AT CT CG AG AT AG TA CAGGTAGTCTTCTGCTTTTT (NR5A2 sh1) and TRCN 0000025985, t ar ge ting C CG GC CC AC AA CA GA CT GA GA AA TT CT CG AG AA TT TC TCAGTCTGTTGTGGGTTTTT (NR5A2 sh2)) previously tested for their efficiency. The knockdown efficiency was analysed by qRT-PCR and immunoblotting. NR0B2 expression was interfered using Mission shRNA lentiviral constructs purchased from Sigma-Aldrich (TRCN0000027118, targeting C C G GC G T CC G A CT A T TC T G TA T G CA C T CG A G TG C A TA CAGAATAGTCGG ACGTTTTT ( N R 0B2 s h 1 ) a nd T RC N0 00 00 27130, t ar ge ting CCGGCA AGGAGTATGCGTACCTGAACTCGAGTTCAGGTACGCATACTCCTTGTT TTT (NR0B2 sh2)). Control cells were transformed using scrambled vector (shNT).
HEK293-FT cells (ATCC) were used to produce lentiviral particles. In brief, cells were allowed to reach 60% of confluence and transfected with 25 μ g of shNT, sh1 or sh2 plasmids together with 30 μ g of psPAX and 10 μ g of pCMV-VSVG helper plasmids using CaCl 2 2 M HBSS, as described earlier. After 12 h, the supernatant was collected and replaced with 5 ml of fresh medium. The supernatant was additionally collected 24 h and 48 h after transfection. The medium was filtered (0.45-μ m pore) and added to 266-6 cells (at 50-60% of confluence). After three rounds of infection, the supernatant was removed and replaced with fresh medium. After one day of recovery, puromycin (2 μ g ml
) (Sigma-Aldrich) was added. Two days later, the medium was replaced and cells were collected for protein and RNA analysis after 24 h. NR0B2 lentiviral overexpression. The production of lentiviral particles and cellular infection were performed as described earlier. The medium from the transfectants was collected 12, 24 and 48 h after transfection. Subsequently, 266-6 cells (obtained from I. Rooman) were infected using polybrene (hexadimethrine bromide, Sigma-Aldrich 107689) (5 μ g ml −1 ). After selection with puromycin, resistant 266-6 cells were collected for RNA and protein analysis.
For combined NR5A2 knockdown and NR0B2 overexpression, cells were first incubated with control shRNA-or NR5A2-targeting lentiviruses. After puromycin selection, resistant 266-6 cells were allowed to recover in fresh medium and incubated with a medium containing lentiviral particles for empty vector or a medium containing lentiviral particles for NR0B2-Flag. Two rounds of infection were performed. After 24 h, the supernatant was removed and fresh medium was added. One day later, 266-6 cells were collected for protein and RNA analyses. Cloning. NR5A2 cDNA was amplified and Flag-tagged by PCR using the following primers: GGGAATTCATGGACTACAAGGACGACGATGACAAGTCT GGCTAGTTTGG and GGGGAATTCTTAGGCTCTTTTGGCATGCAGCA. The PCR product was ligated into the pJET vector and then sub-cloned into pLVXpuro. The human NR0B2 cDNA, tagged with a Flag epitope, was subcloned into the lentiviral vector pLVX-puro. The region encompassing − 1960 to − 655 of the mouse Ccl8 promoter was amplified by PCR and subcloned in pGL3-basic vector (Promega). The sequence of the inserts was confirmed by enzymatic digestion and Sanger sequencing. Luciferase reporter assays. HEK293T cells were transfected with plasmids pcDNA3-NR5A2-Flag and JUN-HA, or the corresponding empty plasmids, together with pRL-TK (Promega) constitutively expressing Renilla luciferase for normalization and transfection efficiency control. Plasmids containing the Ccl8 promoter were included in all the experiments. The amount of transfected plasmids was maintained at a constant level. Transfections were performed using a standard CaCl 2 method and measurements were made in triplicate. After 36 h, cells were lysed in passive lysis buffer (Luciferase kit, Promega E2920) and reporter activity was determined using the Dual-Glo Luciferase Assay system (Promega), according to the manufacturer's instructions. Firefly and Renilla luciferase activities were measured using a luminometer. Other statistical analyses. Comparisons of quantitative data between groups was performed using one-sided Mann-Whitney U test in all cases for which there was a prior hypothesis, except for the data shown in Fig. 1g and Extended Data Fig. 5a . Box plots represent the median and first and third quartiles of the data; error bars are generated by R software and represent the highest and lowest data within 1.5× interquartile range. All statistical analyses were performed with Excel or R software. leads to reduced expression of Jun mRNA but does not affect expression of inflammatory genes (four independent experiments). e, Effects of NR0B2 knockdown on NR5A2 binding to the promoter of acinar, Jun and inflammatory genes (three independent experiments). f, Combined NR5A2 knockdown and NR0B2 overexpression showing that higher levels of NR0B2 are associated with reduced expression of inflammatory gene transcripts, a situation that mimics normal pancreas under basal conditions in wild-type mice (four independent experiments). At least two independent experiments were performed. In c-f, one-sided Mann-Whitney U test; * P < 0.05, * * P < 0.01. 
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There are no restrictions on the availability of our materials or data. b. Describe the method of cell line authentication used. HEK293 cells were not authenticated as they came from ATCC. 266-6 cells are known to the investigators and unique and experimental analyses showed that they are the expected cells (only one mouse cell line with acinar features is available to our knowledge worldwide).
c. Report whether the cell lines were tested for mycoplasma contamination.
Yes, tested and only Mycoplasma-negative cultures were used. No commonly misidentified cell lines were used.
